title: Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
authors: Dominique
authors: D
authors: Crosby
authors: Jeanne
authors: J
authors: Peterson
authors: Brendan T
authors: BT
authors: Carroll
mesh_terms: D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000097:blood / Q000209:etiology* / Q000628:therapy; D000077152:Olanzapine; D011024:Pneumonia, Viral / Q000150:complications / Q000209:etiology; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects; D028761:Withholding Treatment
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D014635:Valproic Acid; D003402:Creatine Kinase; D006220:Haloperidol; D000077152:Olanzapine